Print PDF
Axinn Represents Thermo Fisher in $1.3B Acquisition of Affymetrix
January 11, 2016

Axinn is representing Thermo Fisher Scientific Inc. in its $1.3 billion acquisition of Affymetrix, a leading provider of cellular and genetic analysis products. The Axinn team consists of John Harkrider, Mark Alexander and Kail Jethmalani.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.